(VIANEWS) – Shares of Catalyst Pharmaceuticals (NASDAQ Composite: CPRX) jumped 7.19% to $6.56 at 12:20 EST on Thursday, following the last session’s downward trend. NASDAQ Composite is rising 1.65% to $14,740.58, following the last session’s upward trend. This seems, so far, an all-around positive trend trading session today.

Catalyst Pharmaceuticals’s last close was $5.21, 16.91% under its 52-week high of $6.27.


Today’s last reported volume for Catalyst Pharmaceuticals is 1296087 which is 55.09% above its average volume of 835695.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the current quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.


Catalyst Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a negative 1.73%, a negative 0.21%, and a positive 1.71%, respectively.

Catalyst Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.73% (last week), 1.54% (last month), and 1.71% (last quarter), respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $6.56 at 12:20 EST, above its 52-week high of $6.27.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is way above its 50-day moving average of $5.27 and way above its 200-day moving average of $5.27.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here